Lawrenceville, GEORGIA2 Active Studies

Ankylosing Spondylitis Clinical Trials in Lawrenceville, GEORGIA

Find 2 actively recruiting ankylosing spondylitis clinical trials in Lawrenceville, GEORGIA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
185
Enrolling

Recruiting Ankylosing Spondylitis Studies in Lawrenceville

About Ankylosing Spondylitis Clinical Trials in Lawrenceville

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Lawrenceville, GEORGIA. These studies are seeking a combined 185 participants. Research is being sponsored by Novartis Pharmaceuticals, Vertex Pharmaceuticals Incorporated. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Lawrenceville — FAQ

Are there ankylosing spondylitis clinical trials in Lawrenceville?

Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Lawrenceville, GEORGIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Lawrenceville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lawrenceville research site will contact you about next steps.

Are clinical trials in Lawrenceville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lawrenceville studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 2 active trials in Lawrenceville are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov